About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Fasltm2.1Bksa
targeted mutation 2.1, Bruce R Ksander
MGI:5006688
Summary 3 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Fasltm2.1Bksa/Fasltm2.1Bksa D2.129-Fasltm2.1Bksa MGI:5006704
hm2
Fasltm2.1Bksa/Fasltm2.1Bksa involves: 129 * C57BL/6 MGI:5006702
cx3
Faslpr/Faslpr
Fasltm2.1Bksa/Fasltm2.1Bksa
involves: 129 * C57BL/6 * MRL/Mp MGI:5006703


Genotype
MGI:5006704
hm1
Allelic
Composition
Fasltm2.1Bksa/Fasltm2.1Bksa
Genetic
Background
D2.129-Fasltm2.1Bksa
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Fasltm2.1Bksa mutation (0 available); any Fasl mutation (37 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
vision/eye
N
• mice develop glaucoma as in DBA/2J control mice
• at 12 months, mice exhibit premature retinal ganglion cell loss due to apoptosis compared with similarly treated wild-type mice
• at 12 months, mice exhibit retinal degeneration in all layers of the retina unlike in wild-type mice
• at 5 and 12 months, mice exhibit loss of retinal nerve fibers unlike wild-type mice

nervous system
• at 12 months, mice exhibit premature retinal ganglion cell loss due to apoptosis compared with similarly treated wild-type mice
• at 12 months, mice exhibit retinal degeneration in all layers of the retina unlike in wild-type mice




Genotype
MGI:5006702
hm2
Allelic
Composition
Fasltm2.1Bksa/Fasltm2.1Bksa
Genetic
Background
involves: 129 * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Fasltm2.1Bksa mutation (0 available); any Fasl mutation (37 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
vision/eye
N
• untreated mice exhibit normal retina morphology
• TNFalpha-treated mice exhibit increased apoptosis in the retinal ganglion layer unlike similarly treated wild-type mice
• in saline- or TNFalpha-treated mice
• after 1 week, TNFalpha-treated mice exhibit premature retinal ganglion cell loss due to apoptosis compared with similarly treated wild-type mice
• after 1 week, TNFa-treated mice exhibit premature loss of retinal nerve fibers unlike similarly treated wild-type mice

nervous system
• in saline- or TNFalpha-treated mice
• after 1 week, TNFalpha-treated mice exhibit premature retinal ganglion cell loss due to apoptosis compared with similarly treated wild-type mice

cellular
• TNFalpha-treated mice exhibit increased apoptosis in the retinal ganglion layer unlike similarly treated wild-type mice




Genotype
MGI:5006703
cx3
Allelic
Composition
Faslpr/Faslpr
Fasltm2.1Bksa/Fasltm2.1Bksa
Genetic
Background
involves: 129 * C57BL/6 * MRL/Mp
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Faslpr mutation (39 available); any Fas mutation (82 available)
Fasltm2.1Bksa mutation (0 available); any Fasl mutation (37 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
vision/eye
N
• TNFalpha-treated mice do not exhibit a decrease in retinal nerve fibers like in similarly treated wild-type mice
• after 1 week, TNFalpha-treated mice fail to exhibit a decrease in retinal ganglion cells unlike in similarly treated wild-type mice

nervous system
• after 1 week, TNFalpha-treated mice fail to exhibit a decrease in retinal ganglion cells unlike in similarly treated wild-type mice





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
12/10/2024
MGI 6.24
The Jackson Laboratory